studies and me
Welcome to Studies&Me

The future of treatment development

About us

Setting new standards in
clinical research

As Europe's first virtual contract research organisation, we're on a mission to transform the world of clinical research. By digitalizing all stages of the study, and actively engaging patients as our design partners, we are able to create end-to-end experiences that reach previously excluded patient populations, and deliver superior outcomes for participants, investigators and sponsors alike.

Our Vision

The right treatment,
at the right time.

Delivering superior clinical studies that put patients first is the heart of our business today. But what about the future? Two words: Personalized treatment. This exciting new approach for disease treatment uses a patient centric-approach to treatment development that takes into account a person's individual variability in environment and lifestyle, along with their genetic and physiological makeup. The result? A new era of medicine – one that delivers the right treatment, at the right time.

Our Services

Everything you need in one place

Why coordinate between multiple vendors to get one job done? With us, you don't have to. We deliver every aspect of your study from start to finish. Our services include:

check
Tailored mobile app design
check
Project management
check
Protocol writing & submission
check
Patient research & recruitment

See more

Our studies

Diabetes2Digital

Studies&Me has finalized a decentralized pilot study to test the data quality of blood sugar and behaviometric monitoring of type 2 diabetes patients in collaboration with Glostrup Pharmacy.

Download press release (PDF)

Geno-ME

Studies&Me is conducting a decentralized clinical study in collaboration with Bispebjerg Hospital to investigate how genetics affect Atopic Dermatitis (AD).

Download press release, in Danish (PDF)

COAKS

Studies&Me is conducting a combined phase 1/2a interventional study for Coegin Pharma’s topical AVX001 in the treatment of precancerous skin lesions, Actinic Keratosis.

Download press release (PDF)

Why go digital?

Virtual and hybrid-virtual trials are more than just a trend for strange and uncertain times. They present significant advantages over traditional brick-and-mortar trials, and unique attributes that enhance outcomes for sponsors, investigators and patients alike.

Less site visits

Less site visits

Increased study task compliance

Increased study task compliance

Automatic randomization

Automatic randomization

Real world data

Real world data

Reduced recall bias

Reduced recall bias

Easier recruitment

Easier recruitment

Increased patient engagement

Increased patient engagement

Faster data collection & processing

Faster data collection & processing

Enhanced visibility for investigators

Enhanced visibility for investigators

Decreased patient burden

Decreased patient burden

What our participants say

user icon
"If you came to me and said, “you want to start over?”, I would say “Very much. With pleasure!” I'm sorry I was not allowed to attend for a longer time."
user icon
"The best part for me was getting to know more about my own illness. This study made me open my eyes"
user icon
"This is the very first time I have been in a virtual study. It has been quite an experience. I just had to get used to it, but it has actually worked very well."

Recent News

How can a Decentralized Trial Approach make a difference to treatment of Actinic Keratosis?

BioStock.se

Milestone reach in the collaboration between Studies&Me and Coegin Pharma

BioStock.se

Stars in the Innovative Ecosystem: Interview with John Zibert

EMG-gold.com

Interview with PI Merete Haedersdal about our AK study

BioStock.se

Studies&Me engages in a collaboration with Coegin Pharma AB

medwatch.dk

Patienter skal medudvikle fremtidens behandlinger hjemme fra dagligstuen

jyllands-posten.dk

Medicinforsøg med smartphone-billeder: »Hele situationen med covid-19 har gjort os ekstremt relevante

finans.dk

Digitale værktøjer kan centralisere medicinforsøg

finans.dk

Studies&Me establishes a unique collaboration with Glostrup Pharmacy

medwatch.dk

Our Publications

Smartphone data offer insights into disease activity and triggers in atopic dermatitis: a fully decentralised remote longitudinal pilot study

pubmed.gov

Decentraliserede Kliniske Forsøg

UgeskriftforLæger.dk

Agreement between dermatologists' selection of the lesional area and characteristics best representing atopic dermatitis severity

JAAD.online

Smart button and app to help atopic dermatitis patients in clinical study

pubmed.gov

COVID-19 pandemic pushes clinical trials to go virtual

medium.com

COVID-19 spurs the need for remote assessments in clinical research

medium.com

Virtual Clinical Trials: Perspectives in Dermatology

pubmed.gov

High adherence and low dropout rate...

pubmed.gov